Lipocine $LPCN 4th Submission Run-up
Lipocine Inc 
LPCN has a PDUFA on Aug. 28 for Tlando, a novel oral prodrug of testosterone containing testosterone undecanoate, is designed to help restore normal testosterone levels in hypogonadal men.
Lipocine Announces Derivative Suit Was Dismissed 7/31/2020
prnewswire.com/news-releases/lipocine-announces-derivative-suit-was-dismissed-301103629.html
I really like how this chart is setting up over the $1.60 level if volume continues. There is a lot of short squeeze potential in the name, and always manage your risk.
LPCN has a PDUFA on Aug. 28 for Tlando, a novel oral prodrug of testosterone containing testosterone undecanoate, is designed to help restore normal testosterone levels in hypogonadal men. Lipocine Announces Derivative Suit Was Dismissed 7/31/2020
prnewswire.com/news-releases/lipocine-announces-derivative-suit-was-dismissed-301103629.html
I really like how this chart is setting up over the $1.60 level if volume continues. There is a lot of short squeeze potential in the name, and always manage your risk.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.